The Latest Breaking News from Doximity

The health care software leader offers a buy point following a 50% surge in recent weeks.

Pay increased nearly 6% in 2023—not enough to account for inflation and low reimbursements, found Doximity.

Upgrades

Doximity's (NYSE:DOCS) short percent of float has risen 3.27% since its last report. The company recently reported that it has 7.21 million shares sold short, which is 8.22% of all regular shares that are available for trading.

Someone with a lot of money to spend has taken a bearish stance on Doximity (NYSE:DOCS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Doximity Inc (NYSE: DOCS) shares are trading lower Wednesday after the company reported financial results and issued quarterly guidance below analyst estimates.

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:

Doximity Inc (NYSE:DOCS) reported fourth-quarter revenue growth of 40.4% year-over-year to $93.7 million, beating the consensus of $90.11 million. Adjusted net income was $44.9 million versus $24 million in 4Q21, representing a 48% margin. Adjusted EPS was $0.21, beating the consensus of $0.15. Adjusted gross margin expanded by 200 bps to 90%.…

Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings: